Central retinal vein occlusion associated with platelet activation

Area of Science:

• Ophthalmology
• Hematology
• Vascular Biology

Background:

• Central retinal vein occlusion (CRVO) is a significant cause of vision loss.
• Platelet activation is implicated in thrombotic events, but its role in CRVO requires further elucidation.

Purpose of the Study:

• To compare platelet activation parameters between patients with nonischemic CRVO and healthy controls.
• To investigate the association of mean platelet volume (MPV), platelet distribution width (PDW), and plateletcrit (PCT) with CRVO.

Main Methods:

• A case-control study involving 30 patients with nonischemic CRVO and 30 age- and sex-matched controls.
• Measurement of MPV, PDW, and PCT levels in all participants using standard laboratory techniques.

Main Results:

• Patients with CRVO exhibited significantly higher levels of MPV (10.01 ± 0.89 fl vs. 8.74 ± 1.45 fl), PDW (14.31 ± 1.49% vs. 11.65 ± 1.81%), and PCT (0.27 ± 0.07% vs. 0.23 ± 0.07%) compared to controls (p < 0.05).

Conclusions:

• Elevated MPV, PDW, and PCT suggest subclinical platelet activation in CRVO.
• These platelet indices may contribute to the pathogenesis of central retinal vein occlusion and could inform clinical management strategies.